| 8OV | Name: | N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)propanamide | Formula: | C27 H30 F3 N7 O3 | SMILES: | n1cc(c(nc1Nc2c(cc(cc2)N3CCN(C(=O)C)CC3)OC)Nc4cccc(c4)NC(CC)=O)C(F)(F)F | InChi: | InChI=1S/C27H30F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h5-9,14-16H,4,10-13H2,1-3H3,(H,32,39)(H2,31,33,34,35) | Definition date: | 2017-02-23 | Last modified: | 2024-09-27 | Release date: | 2017-10-18 | Identifier: | N-(3-{[2-{[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)propanamide |
|
| 8PM | Name: | N~2~-{[7-(dimethylamino)-2,1,3-benzothiadiazol-4-yl]sulfonyl}-N-hexyl-N~2~-methylglycinamide | Formula: | C17 H27 N5 O3 S2 | SMILES: | c1(c2c(c(N(C)C)cc1)nsn2)S(=O)(N(C)CC(NCCCCCC)=O)=O | InChi: | InChI=1S/C17H27N5O3S2/c1-5-6-7-8-11-18-15(23)12-22(4)27(24,25)14-10-9-13(21(2)3)16-17(14)20-26-19-16/h9-10H,5-8,11-12H2,1-4H3,(H,18,23) | Definition date: | 2017-02-26 | Last modified: | 2024-09-27 | Release date: | 2017-03-08 | Identifier: | N~2~-{[7-(dimethylamino)-2,1,3-benzothiadiazol-4-yl]sulfonyl}-N-hexyl-N~2~-methylglycinamide |
|
| 8Q1 | Name: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate | Formula: | C23 H45 N2 O8 P S | SMILES: | O=C(CCCCCCCCCCC)SCCNC(CCNC(C(C(COP(=O)(O)O)(C)C)O)=O)=O | InChi: | InChI=1S/C23H45N2O8PS/c1-4-5-6-7-8-9-10-11-12-13-20(27)35-17-16-24-19(26)14-15-25-22(29)21(28)23(2,3)18-33-34(30,31)32/h21,28H,4-18H2,1-3H3,(H,24,26)(H,25,29)(H2,30,31,32)/t21-/m0/s1 | Synonyms: | S-dodecanoyl-4'-phosphopantetheine | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2017-06-21 | Identifier: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate |
|
| 8RC | Name: | 6-ethyl-3-[[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazin
e-2-carboxamide | Formula: | C30 H42 N8 O3 | SMILES: | CCc1nc(C(N)=O)c(Nc2ccc(cc2)N3CCC(CC3)N4CCN(C)CC4)nc1O[CH]5CCN(C5)C(=O)C=C | InChi: | InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1 | Synonyms: | Naquotinib | Definition date: | 2017-08-31 | Last modified: | 2024-09-27 | Release date: | 2018-07-11 | Identifier: | 6-ethyl-3-[[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-[(3~{R})-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazine-2-carboxamide |
|
| 8RE | Name: | 3,4-dihydroxylysine | Formula: | C6 H14 N2 O4 | SMILES: | NCC[CH](O)[CH](O)[CH](N)C(O)=O | InChi: | InChI=1S/C6H14N2O4/c7-2-1-3(9)5(10)4(8)6(11)12/h3-5,9-10H,1-2,7-8H2,(H,11,12)/t3-,4-,5-/m0/s1 | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2018-03-14 | Identifier: | (2~{S},3~{R},4~{S})-2,6-bis(azanyl)-3,4-bis(oxidanyl)hexanoic acid |
|
| 8RQ | Name: | ~{N}4-[(4-chlorophenyl)methyl]-~{N}1-(cyclohexylmethyl)-~{N}4-cyclopentyl-~{N}1-[(~{Z})-4-[(~{E})-methyliminomethyl]-5-oxidanyl-hex-4-enyl]benzene-1,4-disulfonamide | Formula: | C33 H46 Cl N3 O5 S2 | SMILES: | CN=CC(CCCN(CC1CCCCC1)[S](=O)(=O)c2ccc(cc2)[S](=O)(=O)N(Cc3ccc(Cl)cc3)C4CCCC4)=C(C)O | InChi: | InChI=1S/C33H46ClN3O5S2/c1-26(38)29(23-35-2)11-8-22-36(24-27-9-4-3-5-10-27)43(39,40)32-18-20-33(21-19-32)44(41,42)37(31-12-6-7-13-31)25-28-14-16-30(34)17-15-28/h14-21,23,27,31,38H,3-13,22,24-25H2,1-2H3/b29-26-,35-23+ | Definition date: | 2017-02-28 | Last modified: | 2024-09-27 | Release date: | 2017-05-10 | Identifier: | ~{N}4-[(4-chlorophenyl)methyl]-~{N}1-(cyclohexylmethyl)-~{N}4-cyclopentyl-~{N}1-[(~{Z})-4-[(~{E})-methyliminomethyl]-5-oxidanyl-hex-4-enyl]benzene-1,4-disulfonamide |
|
| 8RX | Name: | (3~{R})-3-(pent-4-ynylcarbamoyl)pyrrolidine-1-carboximidothioic acid | Formula: | C11 H17 N3 O S | SMILES: | SC(=N)N1CC[CH](C1)C(=O)NCCCC#C | InChi: | InChI=1S/C11H17N3OS/c1-2-3-4-6-13-10(15)9-5-7-14(8-9)11(12)16/h1,9H,3-8H2,(H2,12,16)(H,13,15)/t9-/m1/s1 | Definition date: | 2023-07-14 | Last modified: | 2024-09-27 | Release date: | 2024-01-31 | Identifier: | (3~{R})-3-(pent-4-ynylcarbamoyl)pyrrolidine-1-carboximidothioic acid |
|
| 8SN | Name: | (3~{S},7~{R},10~{R},11~{R},13~{S})-11-methyl-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid | Formula: | C13 H18 N2 O3 | SMILES: | C[CH]1C[CH](N2[CH]1C=C[CH]3CCN[CH]3C2=O)C(O)=O | InChi: | InChI=1S/C13H18N2O3/c1-7-6-10(13(17)18)15-9(7)3-2-8-4-5-14-11(8)12(15)16/h2-3,7-11,14H,4-6H2,1H3,(H,17,18)/t7-,8+,9+,10+,11+/m1/s1 | Definition date: | 2017-03-03 | Last modified: | 2024-09-27 | Release date: | 2018-03-21 | Identifier: | (3~{S},7~{R},10~{R},11~{R},13~{S})-11-methyl-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid |
|
| 8SU | Name: | (~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid | Formula: | C20 H30 O4 | SMILES: | CCCCC[CH](O)C=C[CH]1C=CC(=O)[CH]1CC=CCCCC(O)=O | InChi: | InChI=1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1 | Synonyms: | PROSTAGLANDIN A2 (PGA2) | Definition date: | 2017-09-12 | Last modified: | 2024-09-27 | Release date: | 2019-03-27 | Identifier: | (~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid |
|
| 8T6 | Name: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide | Formula: | C23 H32 N4 O4 | SMILES: | CC(C)(C)CC(NC(=O)c1cc2ccccc2[NH]1)C(=O)NC(CC1CCNC1=O)CO | InChi: | InChI=1S/C23H32N4O4/c1-23(2,3)12-19(22(31)25-16(13-28)10-15-8-9-24-20(15)29)27-21(30)18-11-14-6-4-5-7-17(14)26-18/h4-7,11,15-16,19,26,28H,8-10,12-13H2,1-3H3,(H,24,29)(H,25,31)(H,27,30)/t15-,16-,19-/m0/s1 | Definition date: | 2021-09-30 | Last modified: | 2024-09-27 | Release date: | 2022-11-09 | Identifier: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide |
|
| 8TQ | Name: | (3~{S},7~{R},10~{R},13~{S})-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carbaldehyde | Formula: | C12 H16 N2 O2 | SMILES: | O=C[CH]1CC[CH]2C=C[CH]3CCN[CH]3C(=O)N12 | InChi: | InChI=1S/C12H16N2O2/c15-7-10-4-3-9-2-1-8-5-6-13-11(8)12(16)14(9)10/h1-2,7-11,13H,3-6H2/t8-,9-,10-,11-/m0/s1 | Definition date: | 2017-03-07 | Last modified: | 2024-09-27 | Release date: | 2018-03-21 | Identifier: | (3~{S},7~{R},10~{R},13~{S})-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carbaldehyde |
|
| 8UI | Name: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | Formula: | C24 H34 N4 O5 | SMILES: | COc1cccc2[NH]c(cc12)C(=O)NC(CC(C)(C)C)C(=O)NC(CC1CCNC1=O)CO | InChi: | InChI=1S/C24H34N4O5/c1-24(2,3)12-19(23(32)26-15(13-29)10-14-8-9-25-21(14)30)28-22(31)18-11-16-17(27-18)6-5-7-20(16)33-4/h5-7,11,14-15,19,27,29H,8-10,12-13H2,1-4H3,(H,25,30)(H,26,32)(H,28,31)/t14-,15-,19-/m0/s1 | Definition date: | 2021-09-30 | Last modified: | 2024-09-27 | Release date: | 2022-11-09 | Identifier: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4,4-dimethyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide |
|
| 8VH | Name: | 1,3-dimethylbenzene | Formula: | C8 H10 | SMILES: | Cc1cccc(C)c1 | InChi: | InChI=1S/C8H10/c1-7-4-3-5-8(2)6-7/h3-6H,1-2H3 | Definition date: | 2017-03-13 | Last modified: | 2024-09-27 | Release date: | 2017-09-13 | Identifier: | 1,3-dimethylbenzene |
|
| 8VY | Name: | 1,3-bis(bromomethyl)benzene | Formula: | C8 H8 Br2 | SMILES: | BrCc1cccc(CBr)c1 | InChi: | InChI=1S/C8H8Br2/c9-5-7-2-1-3-8(4-7)6-10/h1-4H,5-6H2 | Synonyms: | alpha,alpha'-dibromo-m-xylene | Definition date: | 2017-03-08 | Last modified: | 2024-09-27 | Release date: | 2017-07-19 | Identifier: | 1,3-bis(bromomethyl)benzene |
|
| 8W0 | Name: | propyl (3~{S})-4-[[(6~{R})-6-(aminomethyl)-5,6,7,8-tetrahydroacridin-3-yl]carbonyl]-3-methyl-piperazine-1-carboxylate | Formula: | C24 H32 N4 O3 | SMILES: | CCCOC(=O)N1CCN([CH](C)C1)C(=O)c2ccc3cc4CC[CH](CN)Cc4nc3c2 | InChi: | InChI=1S/C24H32N4O3/c1-3-10-31-24(30)27-8-9-28(16(2)15-27)23(29)20-7-6-19-12-18-5-4-17(14-25)11-21(18)26-22(19)13-20/h6-7,12-13,16-17H,3-5,8-11,14-15,25H2,1-2H3/t16-,17+/m0/s1 | Definition date: | 2017-10-12 | Last modified: | 2024-09-27 | Release date: | 2018-10-17 | Identifier: | propyl (3~{S})-4-[[(6~{R})-6-(aminomethyl)-5,6,7,8-tetrahydroacridin-3-yl]carbonyl]-3-methyl-piperazine-1-carboxylate |
|
| CUW | Name: | (2~{S},3~{R})-2,6-bis(azanyl)-3-oxidanyl-hexanoic acid | Formula: | C6 H14 N2 O3 | SMILES: | NCCC[CH](O)[CH](N)C(O)=O | InChi: | InChI=1S/C6H14N2O3/c7-3-1-2-4(9)5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1 | Synonyms: | 3-hydroxy-L-lysine | Definition date: | 2017-12-05 | Last modified: | 2024-09-27 | Release date: | 2018-11-14 | Identifier: | (2~{S},3~{R})-2,6-bis(azanyl)-3-oxidanyl-hexanoic acid |
|
| CUX | Name: | 2-[[7-[(2~{R},3~{R},4~{S},5~{R})-5-[(~{R})-(4-chlorophenyl)-oxidanyl-methyl]-3,4-bis(oxidanyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanal | Formula: | C19 H19 Cl N4 O5 | SMILES: | O[CH]1[CH](O)[CH](O[CH]1[CH](O)c2ccc(Cl)cc2)n3ccc4c(NCC=O)ncnc34 | InChi: | InChI=1S/C19H19ClN4O5/c20-11-3-1-10(2-4-11)13(26)16-14(27)15(28)19(29-16)24-7-5-12-17(21-6-8-25)22-9-23-18(12)24/h1-5,7-9,13-16,19,26-28H,6H2,(H,21,22,23)/t13-,14+,15-,16-,19-/m1/s1 | Definition date: | 2019-05-16 | Last modified: | 2024-09-27 | Release date: | 2019-06-19 | Identifier: | 2-[[7-[(2~{R},3~{R},4~{S},5~{R})-5-[(~{R})-(4-chlorophenyl)-oxidanyl-methyl]-3,4-bis(oxidanyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanal |
|
| CVB | Name: | 4-(CARBOXYVIN-2-YL)PHENYLBORONIC ACID | Formula: | C9 H9 B O4 | SMILES: | O=C(O)C=Cc1ccc(B(O)O)cc1 | InChi: | InChI=1S/C9H9BO4/c11-9(12)6-3-7-1-4-8(5-2-7)10(13)14/h1-6,13-14H,(H,11,12)/b6-3+ | Definition date: | 2001-11-20 | Last modified: | 2024-09-27 | Identifier: | (2E)-3-[4-(dihydroxyboranyl)phenyl]prop-2-enoic acid |
|
| CVE | Name: | (3~{S})-3-[[(2~{R})-2-[3-methyl-2,6-bis(oxidanylidene)-5-[[4-(quinoxalin-2-ylamino)phenyl]carbonylamino]pyrimidin-1-yl]propanoyl]amino]-4-oxidanyl-butanoic acid | Formula: | C27 H27 N7 O7 | SMILES: | C[CH](N1C(=O)N(C)C=C(NC(=O)c2ccc(Nc3cnc4ccccc4n3)cc2)C1=O)C(=O)N[CH](CO)CC(O)=O | InChi: | InChI=1S/C27H27N7O7/c1-15(24(38)30-18(14-35)11-23(36)37)34-26(40)21(13-33(2)27(34)41)32-25(39)16-7-9-17(10-8-16)29-22-12-28-19-5-3-4-6-20(19)31-22/h3-10,12-13,15,18,35H,11,14H2,1-2H3,(H,29,31)(H,30,38)(H,32,39)(H,36,37)/t15-,18+/m1/s1 | Definition date: | 2017-12-07 | Last modified: | 2024-09-27 | Release date: | 2018-05-02 | Identifier: | (3~{S})-3-[[(2~{R})-2-[3-methyl-2,6-bis(oxidanylidene)-5-[[4-(quinoxalin-2-ylamino)phenyl]carbonylamino]pyrimidin-1-yl]propanoyl]amino]-4-oxidanyl-butanoic acid |
|
| CW2 | Name: | N,N'-(octane-1,8-diyl)bis(2,2-dichloroacetamide) | Formula: | C12 H20 Cl4 N2 O2 | SMILES: | C(Cl)(C(=O)NCCCCCCCCNC(=O)C(Cl)Cl)Cl | InChi: | InChI=1S/C12H20Cl4N2O2/c13-9(14)11(19)17-7-5-3-1-2-4-6-8-18-12(20)10(15)16/h9-10H,1-8H2,(H,17,19)(H,18,20) | Definition date: | 2017-09-14 | Last modified: | 2024-09-27 | Release date: | 2018-01-10 | Identifier: | N,N'-(octane-1,8-diyl)bis(2,2-dichloroacetamide) |
|
| CW8 | Name: | (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile | Formula: | C13 H20 F N3 O | SMILES: | FC1CC(C#N)N(C1)C(=O)C(N)C1CCCCC1 | InChi: | InChI=1S/C13H20FN3O/c14-10-6-11(7-15)17(8-10)13(18)12(16)9-4-2-1-3-5-9/h9-12H,1-6,8,16H2/t10-,11-,12-/m0/s1 | Definition date: | 2021-11-23 | Last modified: | 2024-09-27 | Release date: | 2022-10-05 | Identifier: | (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile |
|
| CWF | Name: | (8S)-8-azanylnonanoic acid | Formula: | C9 H19 N O2 | SMILES: | C[CH](N)CCCCCCC(O)=O | InChi: | InChI=1S/C9H19NO2/c1-8(10)6-4-2-3-5-7-9(11)12/h8H,2-7,10H2,1H3,(H,11,12)/t8-/m0/s1 | Definition date: | 2019-05-24 | Last modified: | 2024-09-27 | Release date: | 2020-02-26 | Identifier: | (8~{S})-8-azanylnonanoic acid |
|
| CWV | Name: | [3-(1-aminoisoquinolin-6-yl)phenyl]boronic acid | Formula: | C15 H13 B N2 O2 | SMILES: | B(O)(O)c3cccc(c2cc1ccnc(N)c1cc2)c3 | InChi: | InChI=1S/C15H13BN2O2/c17-15-14-5-4-11(8-12(14)6-7-18-15)10-2-1-3-13(9-10)16(19)20/h1-9,19-20H,(H2,17,18) | Definition date: | 2017-10-05 | Last modified: | 2024-09-27 | Release date: | 2018-03-21 | Identifier: | [3-(1-aminoisoquinolin-6-yl)phenyl]boronic acid |
|
| CX2 | Name: | 2'-deoxy-5'-O-{(R)-hydroxy[(2-sulfanylethyl)amino]phosphoryl}cytidine | Formula: | C11 H19 N4 O6 P S | SMILES: | O=P(O)(OCC2OC(N1C(=O)N=C(N)C=C1)CC2O)NCCS | InChi: | InChI=1S/C11H19N4O6PS/c12-9-1-3-15(11(17)14-9)10-5-7(16)8(21-10)6-20-22(18,19)13-2-4-23/h1,3,7-8,10,16,23H,2,4-6H2,(H2,12,14,17)(H2,13,18,19)/t7-,8+,10+/m0/s1 | Definition date: | 2009-10-01 | Last modified: | 2024-09-27 | Identifier: | 2'-deoxy-5'-O-{(R)-hydroxy[(2-sulfanylethyl)amino]phosphoryl}cytidine |
|
| CXP | Name: | CYCLOHEXANE PROPIONIC ACID | Formula: | C9 H16 O2 | SMILES: | O=C(O)CCC1CCCCC1 | InChi: | InChI=1S/C9H16O2/c10-9(11)7-6-8-4-2-1-3-5-8/h8H,1-7H2,(H,10,11) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-cyclohexylpropanoic acid |
|